Abstract
People worldwide are still threatened by various complex disease phenotypes, especially cancer which is usually caused by the accumulation of multi-factor-driven alterations. Although drugs achieve the therapeutic functions by targeting particular molecular, the therapies used nowadays against diseases are not effective enough due to the limitation of the knowledge about the drug-disease associations. The rapid increasing of the available experimental data and knowledge enable scientists to reveal drug-disease associations by the systematic integration and analysis. In this review, we show that several computational methods can help us to explain the underlying relationships between pharmacology and pathology. It is expected that newer computational methods will take advantage of heterogeneous and multi-dimensional data and increase the efficacy and safety of existing drugs for disease treatment.
Keywords: Computational biology, drug-disease associations, drug reposition, drug off-target, disease gene, mechanism of action, systems biology, systems pharmacology
Current Drug Discovery Technologies
Title:A Brief Survey on Computational Approaches to Reveal Drug and Disease Associations
Volume: 10 Issue: 2
Author(s): Hsiang-Yuan Yeh, Wei-Chih Lin, Yu-Fen Huang and Von-Wun Soo
Affiliation:
Keywords: Computational biology, drug-disease associations, drug reposition, drug off-target, disease gene, mechanism of action, systems biology, systems pharmacology
Abstract: People worldwide are still threatened by various complex disease phenotypes, especially cancer which is usually caused by the accumulation of multi-factor-driven alterations. Although drugs achieve the therapeutic functions by targeting particular molecular, the therapies used nowadays against diseases are not effective enough due to the limitation of the knowledge about the drug-disease associations. The rapid increasing of the available experimental data and knowledge enable scientists to reveal drug-disease associations by the systematic integration and analysis. In this review, we show that several computational methods can help us to explain the underlying relationships between pharmacology and pathology. It is expected that newer computational methods will take advantage of heterogeneous and multi-dimensional data and increase the efficacy and safety of existing drugs for disease treatment.
Export Options
About this article
Cite this article as:
Yeh Hsiang-Yuan, Lin Wei-Chih, Huang Yu-Fen and Soo Von-Wun, A Brief Survey on Computational Approaches to Reveal Drug and Disease Associations, Current Drug Discovery Technologies 2013; 10 (2) . https://dx.doi.org/10.2174/1570163811310020004
DOI https://dx.doi.org/10.2174/1570163811310020004 |
Print ISSN 1570-1638 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6220 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Glucagon-like Peptides, the Central Nervous System, and the Regulation of Energy Homeostasis
Current Medicinal Chemistry - Central Nervous System Agents Personalized Medicine in Oncology: A Personal View with Myths and Facts
Current Clinical Pharmacology P2Y Purinoceptors as Potential Emerging Therapeutical Target in Vascular Disease
Current Pharmaceutical Design The Benefits and Side Effects of Bevacizumab for the Treatment of Recurrent Ovarian Cancer
Current Drug Targets Nanoparticles: A Neurotoxicological Perspective
CNS & Neurological Disorders - Drug Targets Metabolic Profiling in Disease Diagnosis, Toxicology and Personalized Healthcare
Current Pharmaceutical Biotechnology Aurora Kinase Inhibitors in Head and Neck Cancer
Current Topics in Medicinal Chemistry Patent Annotations
Recent Patents on Anti-Infective Drug Discovery Molecular Field Analysis (MFA) and Other QSAR Techniques in Development of Phosphatase Inhibitors
Anti-Cancer Agents in Medicinal Chemistry Actions of Adjunctive Nutritional Antioxidants in Periodontitis and Prevalent Systemic Inflammatory Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Transplantation of Pancreatic Islets Immobilized in Alginate-Based Microcapsules: From Animal Studies to Clinical Trials
Micro and Nanosystems Tracking Cell Signaling Protein Expression and Phosphorylation by Innovative Proteomic Solutions
Current Pharmaceutical Biotechnology Anticancer Mechanisms of Berberine: A Good Choice for Glioblastoma Multiforme Therapy
Current Medicinal Chemistry Mechanisms of Immune Modulation by Mesenchymal Stromal Cells and Clinical Translation
Current Molecular Medicine Angiogenesis Inhibitors: Implications for Combination with Conventional Therapies
Current Pharmaceutical Design Impact of the Emulsification-Diffusion Method on the Development of Pharmaceutical Nanoparticles
Recent Patents on Drug Delivery & Formulation Targeting the AKT Pathway in Glioblastoma
Current Pharmaceutical Design Chronic Myeloid Leukemia: Existing Therapeutic Options and Strategies to Overcome Drug Resistance
Mini-Reviews in Medicinal Chemistry Zinc and its Specific Transporters as Potential Targets in Airway Disease
Current Drug Targets Effects of Limonoid Cedrelone on MDA-MB-231 Breast Tumor Cells in vitro
Anti-Cancer Agents in Medicinal Chemistry